YOLFTbeta
Allmed Medical Products Co Ltd Class A

Allmed Medical Products Co Ltd Class A

002950 · SHE · Healthcare / Medical Instruments & Supplies

8.02CNY-0.16 (-1.96%)

Price History

Full chart

Market Stats

Previous Close8.18
Open8.18
Day Range8.00 – 8.19
52-Week Range8.33 – 14.68
Volume3.63M
Market Cap5.41B
P/E (TTM)21.35
Forward P/E0.00
EPS0.40
Dividend Yield1.71%
Beta0.23
50-Day Avg9.01
200-Day Avg10.65

About

Allmed Medical Products Co.,Ltd supplier in medical dressings and infection control solutions in China and internationally. The company offers traditional wound care products include nonwoven and woven gauze swabs, non-adherent pads, drain sponges, abdominal pads, fluffy sponges/bandages, woven gauze and nonwoven gauze balls, eye pads, cotton filled exodontia sponges, packing strips, ribbon gauze, cotton tipped applicators, elastic net bandages, nose bandages, instrument covers, impregnated gauze dressings, adhesive dressings and tapes, wound bandages, kits, and precut gamgee. It also provides advanced wound care products consist of hydrocolloid dressings, hydrocolloid bandages, blister dressings, silicone foam dressings, superabsorbent dressings, silicone scar patches, and alginate dressings; OR consumables, include x-ray woven gauze/nonwoven gauze swabs and balls, neuro and laparotomy sponges, OR towels, and disposable towel drapes. In addition, the company offers infection products, such as SMS fabric, sterilization wraps, surgical gowns, drapes, surgical packs, normal isolation gowns, isolation gowns (various levels), masks, surgical caps, shoe covers, and boot covers. Allmed Medical Products Co.,Ltd was founded in 1997 and is based in Zhijiang, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Jinhai Cui
  • Employees6.16K
  • HeadquartersNo. 18, Qixing Avenue, Zhijiang, China, 443200, China
  • Websitehttps://www.allmed.cn

Leadership

  • Mr. Jinhai CuiChairman of the Board & President · b. 1959
  • Mr. Tiezhu HuangVP & CFO · b. 1975
  • Ms. Hong ChengVice President · b. 1968
  • Ms. Chunjing ChenVice President · b. 1975
  • Mr. Hui CuiVP & Non-Independent Director · b. 1983
  • Mr. Xingwei CuiVP & Non-Independent Director · b. 1994
  • Mr. Xiaocheng ZhengCompany Secretary · b. 1992
  • Tongshan ChenAccounting Supervisor

Financials

Income Statement

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.51B1.59B1.56B1.71B2.03B2.35B3.83B2.93B4.21B2.76B3.33B3.67B
Growth (%)-+5.05%-1.71%+9.82%+18.49%+16.03%+63.00%-23.70%+43.92%-34.53%+20.66%+10.38%
Cost of Revenue1.01B1.06B1.00B1.14B1.40B1.58B2.22B2.05B2.81B2.10B2.40B2.62B
Gross Profit499.62M526.23M555.51M575.08M631.85M777.30M1.61B872.17M1.40B657.93M928.04M1.05B
Gross Margin33.11%33.20%35.65%33.61%31.16%33.04%42.00%29.81%33.22%23.87%27.90%28.61%
Operating Expense299.70M356.90M271.22M291.59M354.26M386.76M268.63M366.30M873.58M488.87M469.58M455.52M
Operating Income199.92M169.32M284.29M283.49M277.59M390.54M1.34B505.87M525.07M169.06M458.46M594.90M
Operating Margin13.25%10.68%18.25%16.57%13.69%16.60%34.99%17.29%12.47%6.13%13.78%16.20%
EBITDA321.85M283.99M391.21M393.71M427.49M558.22M1.50B673.88M718.84M426.24M708.91M569.38M
EBITDA Margin21.33%17.92%25.11%23.01%21.08%23.73%39.08%23.03%17.07%15.46%21.31%15.51%
Net Income198.43M156.98M248.13M233.73M227.78M325.81M1.16B431.21M406.79M110.40M368.68M248.88M
Net Income Margin13.15%9.90%15.93%13.66%11.23%13.85%30.19%14.74%9.66%4.00%11.08%6.78%
R&D-34.39M38.37M45.41M49.74M59.71M118.13M94.58M107.74M77.37M106.37M104.05M
R&D as % of Total Revenue-2.17%2.46%2.65%2.45%2.54%3.08%3.23%2.56%2.81%3.20%2.83%
Interest Expense33.23M21.43M17.92M26.97M39.99M42.69M17.66M23.27M41.74M33.20M26.64M17.67M
Interest Expense % of Total Revenue2.20%1.35%1.15%1.58%1.97%1.81%0.46%0.80%0.99%1.20%0.80%0.48%

Balance Sheet

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.75B1.85B1.90B2.27B2.90B3.16B4.86B5.00B5.75B5.08B5.06B5.61B
Total Liabilities1.01B854.02M879.11M1.17B1.58B1.10B1.93B2.25B2.62B1.87B1.61B1.99B
Total Equity725.14M981.63M1.01B1.09B1.31B2.05B2.91B2.75B3.10B3.19B3.44B3.60B
Cash239.03M185.12M307.30M200.29M309.60M242.53M1.30B678.46M522.20M397.04M585.16M967.62M
Total Debt753.17M481.69M442.88M636.49M1.07B582.99M1.19B1.29B932.79M900.50M583.91M-
Net Debt514.14M296.57M135.58M436.20M765.19M340.46M-116.13M610.66M410.59M503.46M-1.25M-

Cash Flow

Currency: CNY2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow293.45M217.68M472.74M197.25M3.01M273.13M1.44B374.85M1.15B423.50M711.64M717.13M
Investing Cash Flow-68.24M-87.65M-198.35M-392.86M-278.00M-217.82M-744.82M-473.12M-970.52M-218.25M-144.66M-
Financing Cash Flow-183.71M-88.91M-198.55M113.36M392.18M-85.94M358.69M-552.75M-236.41M-328.81M-390.15M-
Capital Expenditure94.19M99.92M160.47M405.55M287.07M232.55M243.28M290.70M398.05M286.48M157.00M260.32M
Free Cash Flow199.25M117.76M312.27M-208.30M-284.06M40.58M1.19B84.16M751.68M137.02M554.64M456.81M
Dividends Paid70.93M98.38M295.03M185.93M35.15M63.33M253.31M557.27M132.99M65.21M44.11M52.34M
FCF to OCF67.90%54.10%66.06%-105.60%-9441.50%14.86%83.07%22.45%65.38%32.35%77.94%63.70%
Dividend Paid to FCF35.60%83.55%94.48%-89.26%-12.37%156.05%21.22%662.18%17.69%47.59%7.95%11.46%

Earnings

Report DateMar 31, 2019Jun 30, 2019Nov 27, 2019Apr 29, 2020Aug 19, 2020Oct 22, 2020Apr 15, 2021Aug 29, 2021Oct 29, 2021Apr 25, 2022Aug 30, 2022Oct 31, 2022Apr 28, 2023Aug 29, 2023Oct 27, 2023Apr 29, 2024Aug 31, 2024Oct 30, 2024Apr 25, 2025Aug 27, 2025Oct 30, 2025Apr 28, 2026Jun 30, 2026
EPS Estimate-----------------------
EPS Actual0.090.090.170.140.980.390.320.190.140.160.21-0.150.200.05-0.010.150.150.130.140.180.24-0.160.14
Surprise-----------------------
Timing----Pre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-market--After-hoursAfter-hoursPre-marketPre-market-Pre-marketAfter-hours----

Key Statistics & Ratios

Market Cap5.41B
Enterprise Value6.22B
Trailing P/E21.35
Forward P/E0.00
Price / Sales1.41
Price / Book1.48
EPS0.40
Book Value6.00
Revenue (TTM)3.83B
Gross Profit (TTM)1.16B
EBITDA833.92M
Profit Margin6.33%
Operating Margin14.21%
Return on Equity7.07%
Return on Assets6.85%
Shares Outstanding633.27M
Shares Float362.98M
Beta0.23
Dividend Yield1.71%
Dividend Rate0.15
Payout Ratio67.37%

Dividends

20261×
0.15Jun 24, 2026
20251×
0.06Jun 19, 2025
20241×
0.03Jun 19, 2024
20231×
0.06Jun 14, 2023
20221×
0.21Jun 9, 2022
20211×
0.88Jun 16, 2021
20201×
0.40Jun 5, 2020
20191×
0.10Jun 21, 2019

Stock Splits

  • Jun 5, 20201.5:1